As expected, both flow cytometry and cholesterol assay kit analyses demonstrated that the deletion of RNASET2 resulted in elevated cholesterol levels in HCC cells (Figure 2H,I; Figure S3C, Supporting Information). The gene discussed is RNASET2; the disease is hepatocellular carcinoma.